Last Updated : April 25, 2025
Details
| Call for patient/clinician input open | 10-May-24 |
|---|---|
| Call for patient/clinician input closed | 08-Jul-24 |
| Submission received | 21-Jun-24 |
| Submission accepted | 08-Jul-24 |
| Review initiated | 09-Jul-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 23-Sep-24 |
| Deadline for sponsors comments | 03-Oct-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 31-Oct-24 |
| Expert committee meeting (initial) | 13-Nov-24 |
| Draft recommendation issued to sponsor | 27-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 05-Dec-24 |
| End of feedback period | 19-Dec-24 |
| Final recommendation issued to sponsor and drug plans | 10-Jan-25 |
| Final recommendation posted | 29-Jan-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 27-Jan-25 |
| CDA-AMC review report(s) posted | - |